Find uplifting stories about heroes, innovations, and solutions
6 results for "aficamten"
A breakthrough medication could become the first FDA-approved treatment for a common inherited heart disease affecting hundreds of thousands of people. Patients who've lived with limiting symptoms finally have reason for hope.
A breakthrough clinical trial offers the first successful treatment for patients with non-obstructive heart disease who've had zero approved therapies. The drug improved both quality of life and exercise capacity in people living with a challenging heart condition.
A new once-daily pill could transform life for thousands of people in England living with a debilitating heart condition that makes simple activities exhausting. The treatment reached patients two weeks faster than usual thanks to groundbreaking collaboration between health regulators. #
After 27 years, biotech company Cytokinetics could win its second FDA approval in record time with a groundbreaking heart drug. The medication would be the first treatment specifically designed for a type of inherited heart disease that affects thousands of Americans.
A new once-daily pill for a serious heart condition is now available to thousands of patients in England, approved faster than ever thanks to improved coordination between UK health agencies. The treatment offers new hope for people with obstructive hypertrophic cardiomyopathy.
A groundbreaking clinical trial shows the first successful treatment for a debilitating inherited heart condition affecting hundreds of thousands. Patients who struggled to walk up stairs can now hike again.